NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8089
+0.0584 (7.78%)
At close: Apr 28, 2026, 4:00 PM EDT
0.7909
-0.0180 (-2.23%)
After-hours: Apr 28, 2026, 6:19 PM EDT
NeuroSense Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover NeuroSense Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.50, which forecasts a 950.81% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $14.
Price Target: $8.50 (+950.81%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NeuroSense Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,630.75% | Apr 8, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,630.75% | Mar 25, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,630.75% | Mar 17, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +270.87% | Mar 10, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,630.75% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
728.28K
Revenue Next Year
4.98M
from 728.28K
Increased by 583.67%
EPS This Year
-0.32
from -0.44
EPS Next Year
-0.43
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.2M | 8.5M | ||||||
| Avg | 728,280 | 5.0M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,065.9% | ||||||
| Avg | - | 583.7% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.19 | -0.20 | ||||||
| Avg | -0.32 | -0.43 | ||||||
| Low | -0.39 | -0.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.